๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Shanghai

3827 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Multi-cohort, Single-arm, Phase II Study of the Efficacy and Side Effects of Cisplatin Plus Gemcitabine in the Treatment of PD1 Failure or Intensive Treatment of Some Rare Tumors
NCT07046650Advanced Solid Tumors
Sheng Zhang
Phase 2
84
Shanghai
2025-01-01
Active, closed
Electrical Impedance Tomography-Based Dynamic Ventilation-Perfusion Functional Phenotype Trajectory in Acute Respiratory Distress Syndrome
NCT07370610ARDS, Mechanically Ventilated Patients
Ruijin Hospital
Observational
120
Shanghai
2025-01-01
Recruiting
Clinical Evaluation of Non-invasive Blood Glucose Meter
NCT06796322Diabetes Mellitus
Shanghai Jiao Tong University School of Medicine
Not applicable
210
Shanghai
2025-01-01
Recruiting
HAIC Combined with Donafenib and Sintilimab As Perioperative Treatment for Resectable Hepatocellular Carcinoma Patients At High Risk of Recurrence
NCT06812039Hepato Cellular Carcinoma (HCC)
Fudan University
Phase 2
165
Fuzhou, Shanghai, Tianjin
2025-01-01
By invitation
Protective Effect of Probacine Against Negative Gut Metabolism and Organ Dysfunction After Cardiovascular Surgery (PANDA IV)
NCT04444362Cardiovascular Disease, Cardiopulmonary Bypass
Nanjing Medical University
Not applicable
500
Beijing, Guangzhou, Nanjing, Chengdu, Shanghai
2025-01-01
Recruiting
A Multicenter, Prospective, Real-world Study of a Regimen Containing Tucidinostat for Primary Treatment of DLBCL
NCT06779435DLBCL
Ruijin Hospital
Observational
400
Shanghai
2025-01-01
Active, closed
O-RADS MRI System on Early Detection of Ovarian Cancer
NCT07009743Ovarian Cancer (OvCa), Ovarian Cancer Metastatic
Shanghai Gynecologic Oncology Group
Observational
2,549
Shanghai
2025-01-01
Recruiting
Exploratory Study on NIRFI Technology Combined with ICG Guided Cervical Cancer Lymph Node Metastasis
NCT06840418Uterine Cervical Neoplasms
Obstetrics & Gynecology Hospital of Fudan University
Not applicable
15
Shanghai
2025-01-01
Recruiting
Perioperative Toripalimab and Endostatin for Stage II Melanoma: A Phase II Trial
NCT06965231Melanoma of Skin, Acral Melanoma, Stage II Melanoma
Fudan University
Phase 2
58
Shanghai
2025-01-01
Not yet open
The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study
NCT06747299T-NK Cell Lymphoma
Ruijin Hospital
Observational
200
Shanghai
2025-01-01
Recruiting
A Prospective Cohort Study of ITB Treatment for HSP
NCT06844734Hereditary Spastic Paraplegia
Shanghai 6th People's Hospital
Observational
50
Shanghai
2025-01-01
Recruiting
Dual-target iTBS for Youth With ADHD
NCT07084649ADHD
Shanghai Mental Health Center
Phase 1/2
15
Shanghai
2025-01-01
By invitation
Shanghai Atrial Fibrillation Registry
NCT06802965Atrial Fibrillation (AF)
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Observational
400,000
Shanghai
2025-01-01
Recruiting
HAIC Combined With Immune Therapy for Advanced, Non-Resectable ICC
NCT07364305ICC, Advanced Cancer
Eastern Hepatobiliary Surgery Hospital
Phase 2
50
Shanghai
2025-01-01
Recruiting
Comparison of Outcomes Between Femtosecond Laser-Assisted and Conventional Phacoemulsification in Fuchs Endothelial Corneal Dystrophy Patients With Cataracts
NCT06966167Fuchs Endothelial Corneal Dystrophy, Cataract
Eye & ENT Hospital of Fudan University
Observational
120
Shanghai
2025-01-01
Recruiting
Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation
NCT06705062Allogeneic Hematopoietic Cell Transplant, Graft Versus Host Disease
Shanghai Jiao Tong University School of Medicine
Phase 3
316
Shanghai
2025-01-01
Recruiting
The Role of Capsular Tension Rings in Intraocular Lens Stability in High Myopia Cataract Patients: A Prospective Self-Controlled Study
NCT07052825High Myopia, Cataract
Jin Yang
Not applicable
120
Shanghai
2025-01-01
Recruiting
Radical Resection With Contralateral Lymph Node Dissection for Clinical N3 NSCLC
NCT07003490NSCLC, Non Small Cell Lung Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
30
Shanghai
2025-01-01
Recruiting
Indicators and Evaluation of Efficacy of Yin-nourishing and Fire-reducing Chinese Medicine for Girls With Rapid Progression of Early Puberty
NCT06820931Puberty Changes
Children's Hospital of Fudan University
Phase 4
80
Shanghai
2025-01-01
Active, closed
Mindfulness Intervention for Psychological and Family Dynamics in Children with Body-Focused Repetitive Behaviors
NCT06777212Mindfulness Skills, Psychosocial Education
Children's Hospital of Fudan University
Not applicable
200
Shanghai
2025-01-01
By invitation
Multi-center Prospective Clinical Study on Glucocorticoid Pulse Therapy for Graves' Ophthalmopathy (GO)
NCT06693856Graves Ophthalmopathy
Zou Junjie
Not applicable
120
Shanghai
2025-01-01
Active, closed
IL1RAP-targeting Chimeric Antigen Receptor T Cells in the Treatment of Relapsed/Refractory Hepatocellular Carcinoma
NCT06757881HCC
Shanghai Zhongshan Hospital
Phase 1
3
Shanghai
2025-01-01
Recruiting
AI-Enhanced Imaging in Population Breast Cancer Screening
NCT07411443Breast Cancer Screening
Fudan University
Not applicable
16,000
Shanghai
2025-01-01
Recruiting
Trazodone on NREM Sleep Stage โ…ข in Depressed Insomniac Co-morbid Patients
NCT06740188Depressed Insomniac Co-morbid Patients
Tongji University
Phase 4
60
Shanghai
2025-01-01
Not yet open
Clinical Study on Thymus-Kidney Transplantation From Neonatal Donors for the Induction of Immune Tolerance
NCT06715865Kidney Transplant
RenJi Hospital
Not applicable
10
Shanghai
2025-01
Recruiting
HBV-Specific TCR-T Cell Therapy Combined With Nucleos(t)Ide Analogues in Chronic Hepatitis B Patients
NCT06885710Chronic Hepatitis b
Changhai Hospital
Phase 1
19
Shanghai
2024-12-31
Recruiting
Precision Palliative Care for Patients With Advanced Esophageal Cancer
NCT06787313Esophageal Cancer
Fudan University
Observational
624
Shanghai
2024-12-31
Not yet open
Postoperative Sleep Quality and Pain of Patients After Video-Assisted Thoracoscopic Surgery
NCT06633432Sleep Disorder
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Not applicable
316
Shanghai
2024-12-31
Not yet open
Study of HRS-2189 Combined HRS-5041 in Prostate Cancer
NCT06738745Prostate Cancer Metastatic Disease
Fudan University
Phase 2
90
Shanghai
2024-12-31
Not yet open
Periodontal Initial Treatment Combined With Glucocorticoid Therapy for Erosive Oral Lichen Planus
NCT06498180Oral Lichen Planus, Periodontal Diseases
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Not applicable
29
Shanghai
2024-12-31
Recruiting
A Study of HDM2006 in Patients With Advanced Solid Tumor
NCT07377591Advanced Solid Tumors
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 1
48
Shanghai
2024-12-31
Recruiting
Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer
NCT07035002Colorectal Cancer (CRC), Tumor Infiltrating Lymphocytes, PD-1
Ruijin Hospital
Phase 1
29
Shanghai
2024-12-31
Not yet open
Accommodation-Related Visual Training Combined with Transcranial Electrical Stimulation Versus Visual Training Alone for the Treatment of Accommodation Dysfunction
NCT06714890Presbyopia, Esotropia
Eye & ENT Hospital of Fudan University
Not applicable
100
Shanghai
2024-12-31
Not yet open
CD-RCHOP in ND DLBCL With a Combination of TP53 Mutation and Del(17p)
NCT06750991DLBCL
Ruijin Hospital
Phase 2
34
Shanghai
2024-12-31
Active, closed
Comparison Between ER Loss and Triple-Negative Breast Cancer Guided by 18F-FES PET/CT in Metastatic Breast Cancer
NCT07316439Breast Cancer
Fudan University
Observational
197
Shanghai
2024-12-31
Recruiting
Endoscopic Ultrasound-guided Fine-needle Aspiration of Solid Pancreatic Lesions With Rapid Staining of Cytological Smears Followed by Whole Slide Scanning and Artificial Intelligence Diagnosis: A Prospective, Multicenter Study.
NCT06824909Pancreatic Disease
Ruijin Hospital
Observational
1,500
Shanghai
2024-12-31
Not yet open
Safety and Immunogenicity Evaluation of the Recombinant Flagellin Protein Adjuvant
NCT06768697COVID - 19
Shanghai Public Health Clinical Center
Phase EARLY_PHASE1
60
Shanghai
2024-12-30
Active, closed
A Study to Evaluate the Safety, Tolerability, PK, PD, and Preliminary Efficacy of CS01 in Patients With Locally Advanced or Metastatic Solid Tumors
NCT07461181Locally Advanced or Metastatic Solid Tumors
Ruijin Hospital
Phase 1/2
10
Shanghai
2024-12-30
Recruiting
A Clinical Study Exploring CT1190B in the Treatment of Patients with Relapsed/refractory B-cell Non-Hodgkin Lymphoma
NCT06734871B-Cell Non-Hodgkin Lymphoma
Aibin Liang๏ผŒMD๏ผŒPh.D.
Phase 1
24
Shanghai
2024-12-30
Active, closed
A Clinical Study of HT-101 and/or HT-102 in Patients With Chronic Hepatitis B Virus Infection
NCT07183306Chronic Hepatitis B
Suzhou HepaThera Biotech Co., Ltd.
Phase 1/2
86
Beijing, Xiamen, Guangzhou, Qingyuan, Shanghai, Chengdu
2024-12-30
Active, closed
Evaluate the Effectiveness and Safety of the OmniHeart 4.0 Percutaneous Ventricular Assist Device in Providing Hemodynamic Support for Patients Undergoing High-risk Percutaneous Coronary Intervention (PCI).
NCT07622446High-risk PCI
Shanghai Dynaheart Medtech Co., Ltd.
Not applicable
254
Jilin City, Shanghai
2024-12-30
Recruiting
Surufatinib Combined with Envolizumab As Second-line Treatment for Recurrent/Metastatic HNSCC
NCT06876844Head and Neck Cancer, Head and Neck Cancer Squamous Cell Carcinoma
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 2
24
Shanghai
2024-12-30
Recruiting
UCMSCs Combined With Allogeneic Islet Transplantation for the Treatment of Diabetes
NCT06751199Diabetes
Shanghai Changzheng Hospital
Not applicable
16
Shanghai
2024-12-30
Recruiting
68Ga-grazytracer PET/CT for Early Assessment of Response to Neoadjuvant Immunotherapy in Resectable NSCLC
NCT06756217Non-Small Cell Lung Cancer
Ruijin Hospital
Observational
40
Shanghai
2024-12-30
Active, closed
Efficacy and Safety of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
NCT06743646Bietti Crystalline Corneoretinal Dystrophy, Bietti Crystalline Dystrophy
Chigenovo Co., Ltd
Phase 3
62
Beijing, Guangzhou, Haerbin, Zhengzhou, Shanghai, Chengdu, Tianjin, Wenzhou
2024-12-27
Recruiting
Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
NCT06566079Malignant Mesothelioma, Metastatic Malignant Solid Tumor, Advanced Solid Tumor
InSilico Medicine Hong Kong Limited
Phase 1/2
160
Zhengzhou, Shanghai, Beijing, Guangzhou
2024-12-27
Active, closed
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
NCT06593522MTAP-deleted NSCLC
Amgen
Phase 2
61
Beijing, Fuzhou, Zhengzhou, Wuhan, Changsha, Changchun, Jinan, Shanghai
2024-12-26
Not yet open
Comparing the Efficacy of Sintilimab Plus Nab-POF Regimen, Sintilimab Plus XELOX Chemotherapy, and Lenvatinib, Sintilimab Plus XELOX Chemotherapy in the Treatment of HER2-negative, Metastatic Gastric Cancer
NCT06748508Gastric (Stomach) Cancer
Fudan University
Phase 2
141
Shanghai
2024-12-25
Not yet open
Pulsed Field Ablation in Three Different Substrate Ablation Strategies for Persistent Atrial Fibrillation
NCT06739512Atrial Fibrillation (AF)
Shanghai Chest Hospital
Not applicable
600
Shanghai
2024-12-25
Not yet open
Safety and Efficacy Study of Pulsed Electric Field (PEF) Therapy in Patients With Advanced or Unresectable Esophageal Squamous Cell Carcinoma
NCT06756841Esophageal Cancer
Energenx Medical LTD.
Not applicable
10
Shanghai
2024-12-25
Recruiting
Clinical Trial to Evaluate the Efficacy and Safety of Pulsed Electric Field Ablation Devices in the Treatment of Lung Tumors
NCT06739031NSCLC
Energenx Medical LTD.
Not applicable
126
Shanghai
2024-12-25
Recruiting
Total Infectome Characterization of Eye Infections
NCT06775808Eye Infections, Diagnosis
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Observational
200
Shanghai
2024-12-25
Recruiting
An Phase I Trial of a CAR T-cell Infusion C-CAR031 in Participants With GPC3+ Advanced/Metastatic Squamous Cell Lung Cancer
NCT07444281Squamous Cell Lung Cancer
Shanghai AbelZeta Ltd.
Phase 1
24
Shanghai
2024-12-25
Not yet open
Detachable String Magnetically Controlled Capsule Endoscopy for Patients with AUGIB
NCT06725056Acute Upper Gastrointestinal Bleeding, Capsule Endoscopes
Changhai Hospital
Not applicable
120
Shanghai
2024-12-25
Active, closed
A Study of BL-M07D1 Combination Therapy in Patients With Unresectable Locally Advanced or Metastatic HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma
NCT06423885HER2-positive Gastric or Gastroesophageal Junction Adenocarcinoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 2
64
Shanghai
2024-12-24
Recruiting
Cerebellum-Prefrontal Paired-Pulse Stimulation for Methamphetamine Use Disorder
NCT06457230Methamphetamine Use Disorder
Shanghai Mental Health Center
Not applicable
90
Shanghai
2024-12-24
Recruiting
A Study of mRNA Encoding CD19/CD3 T Cell Engager (ABO2203) in Patients With Refractory Autoimmune Diseases
NCT06747156Autoimmune Diseases
Ruijin Hospital
Phase EARLY_PHASE1
66
Wuhan, Nanjing, Shanghai
2024-12-23
Recruiting
CD70-targeted immunoPET Imaging of Malignant Cancers
NCT06852638Renal Cancer, Renal Clear Cell Carcinoma, Lymphoma, Lymphoma, Large B-Cell, Diffuse
RenJi Hospital
Phase 2
300
Shanghai
2024-12-23
By invitation
The Effect of Semi-recumbent Position on Hypoxemia After Lung Segment/Lobe Surgery
NCT07060625Lung Cancer (Diagnosis), Hypoxemia
Shanghai Pulmonary Hospital, Shanghai, China
Observational
308
Shanghai
2024-12-23
Recruiting
Clinical Application Study of PET/CT for Differential Diagnosis of Non-small Cell Lung Cancer
NCT07026110Lung Cancer, Lung Diseases, Lung Neoplasms, Lung Cancer Metastatic
RenJi Hospital
Not applicable
100
Shanghai
2024-12-23
Recruiting
Safety and Preliminary Efficacy of VG801 in Patients With ABCA4 Mutation-associated Retinal Dystrophy (Stargardt Disease)
NCT07002398Retinal Dystrophy Due to Biallelic ABCA4 Mutations, Stargardt Disease 1
VeonGen Therapeutics GmbH
Phase 1/2
18
Shanghai
2024-12-23
Recruiting
Trop2-targeted immunoPET Imaging of Solid Tumors
NCT06851663Solid Tumor, Solid Carcinoma, Uroepithelial Carcinoma, Bladder Cancer
RenJi Hospital
Phase 2/3
400
Shanghai
2024-12-23
Recruiting
Targeting NUDT21 siRNA Drugs for Patients With Refractory Retinoblastoma
NCT06424301Retinoblastoma, Refractory
Eye & ENT Hospital of Fudan University
Phase EARLY_PHASE1
2
Shanghai
2024-12-20
Not yet open
An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis B
NCT06745973Chronic Hepatitis B
Epigenic Therapeutics, Inc
Phase EARLY_PHASE1
20
Shanghai
2024-12-20
Active, closed
A Phase IIb Study of 610 in Participants With Severe Eosinophilic Asthma
NCT06680947Asthma
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 2
225
Shanghai
2024-12-20
Not yet open
Study of Acupuncture to Control Weight and Improve Pregnancy Rates in Overweight/Obese PCOS Patients
NCT06717087Polycystic Ovary Syndrome, Metformin, Acupuncture
RenJi Hospital
Not applicable
92
Shanghai
2024-12-20
Recruiting
A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
NCT06500702Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion
Sanofi
Phase 2
84
Beijing, Chengdu, Shanghai
2024-12-19
Active, closed
A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy
NCT06742190Multifocal Motor Neuropathy (MMN), MMN
argenx
Phase 3
154
Shanghai
2024-12-18
Recruiting
BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC
NCT06793332Triple-Negative Breast Cancer (TNBC), Brain Metastases
Fudan University
Phase 2
39
Shanghai
2024-12-17
Recruiting
A Study of Belantamab Mafodotin Administered in Combination With Lenalidomide and Dexamethasone (BRd) Versus Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Who Are Ineligible for Autologous Stem Cell Transplantation (TI-NDMM)
NCT06679101Multiple Myeloma, Newly Diagnosed Multiple Myeloma
GlaxoSmithKline
Phase 3
520
Beijing, Chengdu, Chongqing, Guangzhou, Hangzhou, Nanchang, Nanjing, Shanghai
2024-12-16
Recruiting
Study of BM230 in Patients With Advanced Solid Tumors
NCT06644300Solid Tumor
Suzhou Biomissile Pharmaceuticals Co., Ltd.
Phase 1
123
Bengbu, Shanghai, Hangzhou
2024-12-16
Not yet open
Efficacy and Safety of Intravenous + Oral Vs. Oral Amiodarone in Preventing Recurrence After Catheter Ablation in Patients with Persistent Atrial Fibrillation
NCT06742866Atrial Fibrillation (AF)
Shanghai Chest Hospital
Not applicable
418
Shanghai
2024-12-16
Active, closed
A Phase III Study of KN026 in Combination With HB1801 ยฑ Carboplatin as Neoadjuvant Treatment for Early or Locally Advanced HER2-Positive Breast Cancer
NCT06747338Early or Locally Advanced HER2-positive Breast Cancer
Shanghai JMT-Bio Inc.
Phase 3
520
Shanghai
2024-12-16
Not yet open
Atrial Fibrillation with Heart Failure with Preserved Ejection Fraction: Treatment Strategies-Catheter Ablation Vs. Anti-Atrial Arrhythmia Drugs
NCT06740539HFpEF - Heart Failure with Preserved Ejection Fraction, Atrial Fibrillation (AF)
Shanghai Chest Hospital
Not applicable
304
Shanghai
2024-12-16
Not yet open
A Single-Arm, Phase โ… b Study of Golidocitinib Combined With Anti-PD-1 for the Treatment of Previously Treated NSCLC
NCT06690671Lung Cancer, Non-Small Cell
Shanghai Chest Hospital
Phase 1/2
30
Shanghai
2024-12-15
Recruiting
Evaluation of a CAM System for Colorectal Polyp Size Measurement
NCT06715384Colorectal Polyp, Colorectal Adenoma
Changhai Hospital
Not applicable
168
Shanghai
2024-12-15
Recruiting
Efficacy and Influencing Factors of ALIC-NAc Deep Brain Stimulation in Treatment-Refractory Obsessive-Compulsive Disorder
NCT07031544Obsessive - Compulsive Disorder
Shanghai Mental Health Center
Not applicable
60
Guangzhou, Shijiazhuang, Xinxiang, Nanchang, Taiyuan, Mianyang, Shanghai, Tianjin
2024-12-14
Active, closed
Study to Evaluate the Efficacy and Safety of VGR-R01 Gene Therapy in Patients With Bietti Crystalline Dystrophy
NCT06699108Bietti Crystalline Dystrophy, Inherited Retinal Diseases
Shanghai Vitalgen BioPharma Co., Ltd.
Phase 3
45
Shanghai
2024-12-13
Recruiting
Clinical Trial of HG146 Administered to Participants With Adenoid Cystic Carcinoma
NCT06781567Adenoid Cystic Carcinoma, Head and Neck Cancer
HitGen Inc.
Phase 2
140
Shanghai
2024-12-13
Recruiting
A Study on the Combined Use of Tocilizumab and Flupentixol-Melitracen in the Treatment of Thyroid-Associated Ophthalmopathy
NCT06927375Thyroid-Associated Ophthalmopathy
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Phase 4
60
Shanghai
2024-12-12
Recruiting
A Phase 1 Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of MK-6204 (SKB535) for Injection in Participants With Advanced Solid Tumors
NCT06726369Advanced Solid Tumors
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Phase 1
90
Beijing, Changsha, Chengdu, Chongqing, Fuzhou, Shanghai, Wuhan
2024-12-12
Recruiting
Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)
NCT06730321Thyroid Cancer, Thyroid Nodule, Thyroid Diseases, Thyroid Cancer, Papillary
Shanghai 6th People's Hospital
Observational
200
Shanghai
2024-12-12
Recruiting
A Dose Escalating Study of CD19/CD22/BCMA CAR-T Therapy in Relapsed/ Refractory Multiple Myeloma
NCT06732232Relapsed, Refractory, Multiple Myeloma
Shanghai Cell Therapy Group Co.,Ltd
Phase EARLY_PHASE1
12
Shanghai
2024-12-12
Recruiting
Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial.
NCT06836505Neuroblastoma (NB), Desmoplastic Small Round Cell Tumor (DSRCT)
Sun Yat-Sen University Cancer Center
Phase 1/2
10
Guangzhou, Dongguan, Shanghai
2024-12-12
Recruiting
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
NCT06716606Connective Tissue Diseases
GlaxoSmithKline
Phase 3
514
Beijing, Chengdu, Hangzhou, Mianyang, Shanghai, Shenyang, Zhuzhou
2024-12-12
Recruiting
a Study of CT0596 in Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Plasma Cell Leukemia
NCT06718270Relapsed/Refractory Multiple Myeloma, Relapsed/Refractory Plasma Cell Leukemia
Shanghai Changzheng Hospital
Phase EARLY_PHASE1
24
Shanghai
2024-12-11
Not yet open
Botulinum Toxin Injection Versus Prism Treatment in Small-angle Acute Acquired Concomitant Esotropia
NCT06714877Esotropia
Eye & ENT Hospital of Fudan University
Not applicable
100
Shanghai
2024-12-10
Recruiting
Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1
NCT06718244Acute Lymphoblastic Leukemia
Ruijin Hospital
Phase 2
20
Shanghai
2024-12-10
Active, closed
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.
NCT06637631Crohn's Disease
Sanofi
Phase 2
260
Changzhou, Chongqing, Fuzhou, Guangzhou, Hangzhou, Hefei, Nanchang, Shanghai
2024-12-10
Recruiting
Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors
NCT06718946Advanced Malignant Solid Tumor
Fudan University
Phase EARLY_PHASE1
38
Shanghai
2024-12-10
By invitation
Intervention Effects of High-intensity Tai Chi in Mild or Moderate Asthma
NCT06728904Asthma
Yufen Wu, MD
Not applicable
35
Shanghai
2024-12-10
Recruiting
CR-CHOP+X in Previously Untreated DEL
NCT06701357DLBCL
Ruijin Hospital
Phase 2
49
Shanghai
2024-12-10
Recruiting
Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression
NCT06717048Myopia, Refractive Error - Myopia, Choroidal Thickness, Retina
Shanghai Eye Disease Prevention and Treatment Center
Not applicable
108
Shanghai
2024-12-09
Recruiting
A Multi-mode Thermophysical Immunotherapy Study for Breast Cancer Liver Metastases
NCT06567353Breast Neoplasms, Liver Neoplasms, Metastasis
Ruijin Hospital
Not applicable
10
Shanghai
2024-12-09
Recruiting
Clinical Trial of TQB3002 in Patients With Advanced Cancers
NCT06662760Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1
150
Guangzhou, Shenzhen, Zhengzhou, Nanjing, Nanchang, Shanghai, Xiโ€™an, Chengdu
2024-12-09
Recruiting
Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
NCT06597019Familial Hypercholesterolemia - Heterozygous
Novartis Pharmaceuticals
Phase 3
60
Beijing, Shanghai
2024-12-09
Recruiting
Intrathecal Injection Pemetrexed And Bevacizumab in Patients With Leptomeningeal Metastases in NSCLC
NCT06663306Lung Cancer (NSCLC), Leptomeningeal Metastasis
Shanghai Chest Hospital
Phase 1
19
Shanghai
2024-12-09
Recruiting
Study of SIM0508 Alone and in Combination in Patients With Advanced Solid Tumors
NCT06686745Advanced Solid Tumors
Jiangsu Simcere Pharmaceutical Co., Ltd.
Phase 1
130
Shanghai, Chongqing
2024-12-06
Recruiting
Efficacy and Safety of Telitacicept in IgAN
NCT06654596IgA Nephropathy (IgAN), Kidney Diseases, Telitacicept, Glucocorticoid
Ruijin Hospital
Not applicable
118
Shanghai
2024-12-06
Recruiting
Study of SC-102 in Patients With Advanced Solid Tumors
NCT06710158Advanced Solid Cancers
Tianjin ConjuStar Biologics Co., Ltd.
Phase 1
120
Shanghai
2024-12-05
Rows per page Showing 1901–2000 of 3827
Previous 18 19 20 21 22 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai?page=20

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 3,827 of those studies with a site in Shanghai.

How many clinical trials are recruiting in Shanghai?

2,393 of the 3,827 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 737 have not yet opened recruitment, 588 are active but closed to new participants, and 109 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.